Conmed (CNMD) Return on Capital Employed (2011 - 2026)
Conmed's (CNMD) quarterly Return on Capital Employed came in at 5.96% in Q2 2026, down 258.0% YoY from 3.77% in Q2 2025, and up 7.75% on a QoQ basis from 5.53% in Q1 2026.
Conmed (CNMD) Return on Capital Employed (2011 - 2026) Analysis & Trends
Conmed (CNMD) has 16 years of Return on Capital Employed data on file, last reported at 5.96% in Q2 2026.
- Quarterly Return on Capital Employed fell 258.0% year-over-year to 5.96% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 5.96% (down 258.0% YoY) and the FY2025 annual result came in at 5.13%, down 476.0% from the prior year.
- Return on Capital Employed advanced to 5.96% in Q2 2026, from 5.53% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 9.85% in Q4 2024 to a low of 3.03% in Q1 2023.
- A 5-year average of 6.28% and a median of 5.99% in 2026 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed soared 625 bps — and 2025, when it plunged 475 bps.
- Tracing CNMD's Return on Capital Employed over 5 years: stood at 3.51% in 2022, then surged by 72 bps to 6.02% in 2023, then jumped by 64 bps to 9.85% in 2024, then tumbled by 48 bps to 5.11% in 2025, then grew by 17 bps to 5.96% in 2026.
- The last three Return on Capital Employed figures came in at 5.96% (Q2 2026), 5.53% (Q1 2026), and 5.11% (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 12.08% |
| 10 | Conmed | 1.55 Bn | 1.51 Bn | 197.46 Mn | 5.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.96% |
| Mar 31, 2026 | 5.53% |
| Dec 31, 2025 | 5.11% |
| Sep 30, 2025 | 5.89% |
| Jun 30, 2025 | 8.54% |
| Mar 31, 2025 | 8.98% |
| Dec 31, 2024 | 9.85% |
| Sep 30, 2024 | 9.81% |
| Jun 30, 2024 | 8.01% |
| Mar 31, 2024 | 7.10% |
| Dec 31, 2023 | 6.02% |
| Sep 30, 2023 | 3.56% |
| Jun 30, 2023 | 3.21% |
| Mar 31, 2023 | 3.03% |
| Dec 31, 2022 | 3.51% |
| Sep 30, 2022 | 5.49% |
| Jun 30, 2022 | 6.41% |
| Mar 31, 2022 | 7.06% |
| Dec 31, 2021 | 7.02% |
| Sep 30, 2021 | 6.17% |